MED
Medifast, Inc.
NYSE · Consumer Cyclical · Personal Products & Services · US
$12.63
+0.72%Year over year
Reported trailing growth
- Revenue
- -34.0%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +265.7%
- Operating cash flow
- +111.7%
Forward estimates
Based on analyst estimates
- Revenue
- -13.0%
- EBITDA
- +225.1%
- EPS
- +70.0%
Three-year CAGR
- Revenue
- -37.7%
- EBITDA
- -70.8%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -80.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026